{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:56:48Z","timestamp":1771653408959,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Acute myeloid leukemia (AML) is a blood cancer characterized by uncontrolled growth of myeloid cells. Overcoming AML treatment resistance, particularly to anthracycline-based drugs like doxorubicin (ADR), poses a challenge. This study investigated the role of CELF1, an RNA-binding protein, in ADR resistance and autophagy regulation in AML. CELF1 expression was elevated in multiple tumor types, including AML. AML cell lines exhibit varying levels of CELF1 expression, with drug-resistant cell lines showing higher CELF1 expression compared to parental cells. CELF1 knockdown reduced drug resistance, promoted cell death, and inhibited autophagy. Mechanistic analysis identified ATG5 as a potential CELF1-regulated target gene, with CELF1 knockdown reducing ATG5 expression and mRNA decay. These findings indicate that targeting CELF1 could overcome ADR resistance in AML by modulating autophagy through ATG5 regulation, highlighting its clinical significance as a therapeutic target for enhancing ADR response in AML.<\/jats:p>","DOI":"10.1038\/s41419-025-07926-0","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T06:30:52Z","timestamp":1754634652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The RNA-binding protein CELF1 targets ATG5 to regulate autophagy and promote drug resistance in acute myeloid leukemia"],"prefix":"10.1038","volume":"16","author":[{"given":"Xiaoyan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiyi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juejiashan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongsheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4375-8466","authenticated-orcid":false,"given":"Wenhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"7926_CR1","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41571-021-00509-w","volume":"18","author":"H D\u00f6hner","year":"2021","unstructured":"D\u00f6hner H, Wei AH, L\u00f6wenberg B. Towards precision medicine for AML. Nat Rev Clin Oncol. 2021;18:577\u201390.","journal-title":"Nat Rev Clin Oncol"},{"key":"7926_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrc989","volume":"3","author":"DG Tenen","year":"2003","unstructured":"Tenen DG. Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer. 2003;3:89\u2013101.","journal-title":"Nat Rev Cancer"},{"key":"7926_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1182\/blood-2015-07-604538","volume":"127","author":"EM Stein","year":"2016","unstructured":"Stein EM, Tallman MS. Emerging therapeutic drugs for AML. Blood. 2016;127:71\u20138.","journal-title":"Blood"},{"key":"7926_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13045-021-01062-w","volume":"14","author":"H Liu","year":"2021","unstructured":"Liu H. Emerging agents and regimens for AML. J Hematol Oncol. 2021;14:49.","journal-title":"J Hematol Oncol"},{"key":"7926_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ccell.2019.01.010","volume":"35","author":"E Wang","year":"2019","unstructured":"Wang E, Lu SX, Pastore A, Chen X, Imig J, Lee SC-W, et al. Targeting an RNA-binding protein network in acute myeloid leukemia. Cancer Cell. 2019;35:369\u201384. e7.","journal-title":"Cancer Cell"},{"key":"7926_CR6","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s43018-021-00220-w","volume":"2","author":"C Prieto","year":"2021","unstructured":"Prieto C, Nguyen DT, Liu Z, Wheat J, Perez A, Gourkanti S, et al. Transcriptional control of CBX5 by the RNA-binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia. Nat Cancer. 2021;2:741\u201357.","journal-title":"Nat Cancer"},{"key":"7926_CR7","doi-asserted-by":"publisher","first-page":"11056","DOI":"10.3390\/ijms222011056","volume":"22","author":"M Nasiri-Aghdam","year":"2021","unstructured":"Nasiri-Aghdam M, Garcia-Gardu\u00f1o TC, Jave-Su\u00e1rez LF. Celf family proteins in cancer: Highlights on the rna-binding protein\/noncoding rna regulatory axis. Int J Mol Sci. 2021;22:11056.","journal-title":"Int J Mol Sci"},{"key":"7926_CR8","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1093\/nar\/24.22.4407","volume":"24","author":"LT Timchenko","year":"1996","unstructured":"Timchenko LT, Miller JW, Timchenko NA, DeVore DR, Datar KV, Lin L, et al. Identification of a (CUG) n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res. 1996;24:4407\u201314.","journal-title":"Nucleic Acids Res"},{"key":"7926_CR9","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1016\/j.bbrc.2018.08.126","volume":"503","author":"K Belanger","year":"2018","unstructured":"Belanger K, Nutter CA, Li J, Tasnim S, Liu P, Yu P, et al. CELF1 contributes to aberrant alternative splicing patterns in the type 1 diabetic heart. Biochem Biophys Res Commun. 2018;503:3205\u201311.","journal-title":"Biochem Biophys Res Commun"},{"key":"7926_CR10","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1042\/CS20191174","volume":"134","author":"H Wang","year":"2020","unstructured":"Wang H, Huang R, Guo W, Qin X, Yang Z, Yuan Z, et al. RNA-binding protein CELF1 enhances cell migration, invasion, and chemoresistance by targeting ETS2 in colorectal cancer. Clin Sci. 2020;134:1973\u201390.","journal-title":"Clin Sci"},{"key":"7926_CR11","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1091\/mbc.E14-11-1500","volume":"26","author":"L Liu","year":"2015","unstructured":"Liu L, Ouyang M, Rao JN, Zou T, Xiao L, Chung HK, et al. Competition between RNA-binding proteins CELF1 and HuR modulates MYC translation and intestinal epithelium renewal. Mol Biol Cell. 2015;26:1797\u2013810.","journal-title":"Mol Biol Cell"},{"key":"7926_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.drup.2012.02.001","volume":"15","author":"BC Shaffer","year":"2012","unstructured":"Shaffer BC, Gillet J-P, Patel C, Baer MR, Bates SE, Gottesman MM. Drug resistance: still a daunting challenge to the successful treatment of AML. Drug Resist Updates. 2012;15:62\u20139.","journal-title":"Drug Resist Updates"},{"key":"7926_CR13","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1038\/s41375-019-0402-3","volume":"33","author":"NA McNeer","year":"2019","unstructured":"McNeer NA, Philip J, Geiger H, Ries RE, Lavallee V-P, Walsh M, et al. Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia. Leukemia. 2019;33:1934\u201343.","journal-title":"Leukemia"},{"key":"7926_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.350","volume":"4","author":"X Sui","year":"2013","unstructured":"Sui X, Chen R, Wang Z, Huang Z, Kong N, Zhang M, et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis. 2013;4:e838-e.","journal-title":"Cell Death Dis"},{"key":"7926_CR15","doi-asserted-by":"crossref","unstructured":"Hou X, Jiang J, Tian Z, Wei L. Autophagy and tumour chemotherapy. In: Weidong Le, editor. Autophagy: Biology and Diseases: Clinical Science. New York: Springer; 2020; 351\u201374.","DOI":"10.1007\/978-981-15-4272-5_24"},{"key":"7926_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7032614","volume":"2022","author":"W Long","year":"2022","unstructured":"Long W, Zhang L, Wang Y, Xie H, Wang L, Yu H. Research progress and prospects of autophagy in the mechanism of multidrug resistance in tumors. J Oncol. 2022;2022:7032614.","journal-title":"J Oncol"},{"key":"7926_CR17","doi-asserted-by":"crossref","unstructured":"Qin Y, Ashrafizadeh M, Mongiardini V, Grimaldi B, Crea F, Rietdorf K, et al. Autophagy and cancer drug resistance in dialogue: pre-clinical and clinical evidence. Cancer Lett. 2023;570:216307.","DOI":"10.1016\/j.canlet.2023.216307"},{"key":"7926_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13045-020-01000-2","volume":"13","author":"H Chang","year":"2020","unstructured":"Chang H, Zou Z. Targeting autophagy to overcome drug resistance: further developments. J Hematol Oncol. 2020;13:159.","journal-title":"J Hematol Oncol"},{"key":"7926_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1080\/15548627.2016.1245263","volume":"13","author":"S Piya","year":"2017","unstructured":"Piya S, Andreeff M, Borthakur G. Targeting autophagy to overcome chemoresistance in acute myleogenous leukemia. Autophagy. 2017;13:214\u20135.","journal-title":"Autophagy"},{"key":"7926_CR20","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1080\/15548627.2020.1822628","volume":"17","author":"W Du","year":"2021","unstructured":"Du W, Xu A, Huang Y, Cao J, Zhu H, Yang B, et al. The role of autophagy in targeted therapy for acute myeloid leukemia. Autophagy. 2021;17:2665\u201379.","journal-title":"Autophagy"},{"key":"7926_CR21","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1038\/s41401-023-01112-8","volume":"44","author":"H-l Wang","year":"2023","unstructured":"Wang H-l, Li J-n, Kan W-j, Xu G-y, Luo G-h, Song N, et al. Chloroquine enhances the efficacy of chemotherapy drugs against acute myeloid leukemia by inactivating the autophagy pathway. Acta Pharmacol Sin. 2023;44:2296\u2013306.","journal-title":"Acta Pharmacol Sin"},{"key":"7926_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/leu.2010.225","volume":"25","author":"L Liu","year":"2011","unstructured":"Liu L, Yang M, Kang R, Wang Z, Zhao Y, Yu Y, et al. HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia. 2011;25:23\u201331.","journal-title":"Leukemia"},{"key":"7926_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04336-w","volume":"12","author":"X Chen","year":"2021","unstructured":"Chen X, Chen X, Huang Y, Lin J, Wu Y, Chen Y. TCP1 increases drug resistance in acute myeloid leukemia by suppressing autophagy via activating AKT\/mTOR signaling. Cell Death Dis. 2021;12:1058.","journal-title":"Cell Death Dis"},{"key":"7926_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2018.03.024","volume":"425","author":"X Hu","year":"2018","unstructured":"Hu X, Mei S, Meng W, Xue S, Jiang L, Yang Y, et al. CXCR4-mediated signaling regulates autophagy and influences acute myeloid leukemia cell survival and drug resistance. Cancer Lett. 2018;425:1\u201312.","journal-title":"Cancer Lett"},{"key":"7926_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/wrna.107","volume":"3","author":"T Dasgupta","year":"2012","unstructured":"Dasgupta T, Ladd AN. The importance of CELF control: molecular and biological roles of the CUG\u2010BP, Elav\u2010like family of RNA\u2010binding proteins. Wiley Interdiscip Rev RNA. 2012;3:104\u201321.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"7926_CR26","doi-asserted-by":"publisher","first-page":"8638","DOI":"10.1093\/nar\/gkr510","volume":"39","author":"J Edwards","year":"2011","unstructured":"Edwards J, Malaurie E, Kondrashov A, Long J, de Moor CH, Searle MS, et al. Sequence determinants for the tandem recognition of UGU and CUG rich RNA elements by the two N\u2014terminal RRMs of CELF1. Nucleic Acids Res. 2011;39:8638\u201350.","journal-title":"Nucleic Acids Res"},{"key":"7926_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s11658-024-00556-y","volume":"29","author":"WJ Qin","year":"2024","unstructured":"Qin WJ, Shi J-J, Chen R-Y, Li C-Y, Liu Y-J, Lu J-F, et al. Curriculum vitae of CUG binding protein 1 (CELF1) in homeostasis and diseases: a systematic review. Cell Mol Biol Lett. 2024;29:32.","journal-title":"Cell Mol Biol Lett"},{"key":"7926_CR28","doi-asserted-by":"crossref","unstructured":"Barley K, Navada SC. Acute myeloid leukemia. In: William K. Oh, Ajai Chari editors. Mount Sinai Expert Guides: Oncology. Hoboken, NJ: Wiley\u2011Blackwell; 2019; 308\u201318.","DOI":"10.1002\/9781119189596.ch27"},{"key":"7926_CR29","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/0145-2126(90)90101-E","volume":"14","author":"L Degos","year":"1990","unstructured":"Degos L. Differentiating agents in the treatment of leukemia. Leuk Res. 1990;14:717\u20139.","journal-title":"Leuk Res"},{"key":"7926_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ctrv.2008.09.001","volume":"35","author":"A Kuendgen","year":"2009","unstructured":"Kuendgen A, Germing U. Emerging treatment strategies for acute myeloid leukemia (AML) in the elderly. Cancer Treat Rev. 2009;35:97\u2013120.","journal-title":"Cancer Treat Rev"},{"key":"7926_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1308102","volume":"12","author":"H Vembuli","year":"2024","unstructured":"Vembuli H, Gor R, Ramalingam S, Perales S, Rajasingh J. RNA binding proteins in cancer chemotherapeutic drug resistance. Front Cell Dev Biol. 2024;12:1308102.","journal-title":"Front Cell Dev Biol"},{"key":"7926_CR32","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3390\/ph16081114","volume":"16","author":"Y Feng","year":"2023","unstructured":"Feng Y, Zhu S, Liu T, Zhi G, Shao B, Liu J, et al. Surmounting cancer drug resistance: new perspective on RNA-binding proteins. Pharmaceuticals. 2023;16:1114.","journal-title":"Pharmaceuticals"},{"key":"7926_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114569","volume":"191","author":"M Mehta","year":"2022","unstructured":"Mehta M, Raguraman R, Ramesh R, Munshi A. RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer. Adv Drug Deliv Rev. 2022;191:114569.","journal-title":"Adv Drug Deliv Rev"},{"key":"7926_CR34","doi-asserted-by":"crossref","unstructured":"Zhao Y, Mir C, Garcia-Mayea Y, Paciucci R, Kondoh H, LLeonart M, editors. RNA-binding proteins: underestimated contributors in tumorigenesis. Semin Cancer Biol. 2022;86:431\u201344.","DOI":"10.1016\/j.semcancer.2022.01.010"},{"key":"7926_CR35","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.arr.2012.02.007","volume":"11","author":"K Jones","year":"2012","unstructured":"Jones K, Timchenko L, Timchenko NA. The role of CUGBP1 in age-dependent changes of liver functions. Ageing Res Rev. 2012;11:442\u20139.","journal-title":"Ageing Res Rev"},{"key":"7926_CR36","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.bbadis.2015.04.010","volume":"1852","author":"X Peng","year":"2015","unstructured":"Peng X, Shen X, Chen X, Liang R, Azares AR, Liu Y. Celf1 regulates cell cycle and is partially responsible for defective myoblast differentiation in myotonic dystrophy RNA toxicity. Biochim Biophys Acta. 2015;1852:1490\u20137.","journal-title":"Biochim Biophys Acta"},{"key":"7926_CR37","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s12010-014-0937-8","volume":"173","author":"X Wang","year":"2014","unstructured":"Wang X, Wang H, Ji F, Zhao S, Fang X. Lentivirus-mediated knockdown of CUGBP1 suppresses gastric cancer cell proliferation in vitro. Appl Biochem Biotechnol. 2014;173:1529\u201336.","journal-title":"Appl Biochem Biotechnol"},{"key":"7926_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2867-13-115","volume":"13","author":"LN Wu","year":"2013","unstructured":"Wu LN, Xue YJ, Zhang LJ, Ma XM, Chen JF. Si-RNA mediated knockdown of CELF1 gene suppressed the proliferation of human lung cancer cells. Cancer Cell Int. 2013;13:115.","journal-title":"Cancer Cell Int"},{"key":"7926_CR39","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.7150\/ijbs.11344","volume":"11","author":"L Xia","year":"2015","unstructured":"Xia L, Sun C, Li Q, Feng F, Qiao E, Jiang L, et al. CELF1 is up-regulated in glioma and promotes glioma cell proliferation by suppression of CDKN1B. Int J Biol Sci. 2015;11:1314\u201324.","journal-title":"Int J Biol Sci"},{"key":"7926_CR40","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J Debnath","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24:560\u201375.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7926_CR41","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","volume":"147","author":"N Mizushima","year":"2011","unstructured":"Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147:728\u201341.","journal-title":"Cell"},{"key":"7926_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06154-8","volume":"14","author":"S Liu","year":"2023","unstructured":"Liu S, Yao S, Yang H, Liu S, Wang Y. Autophagy: regulator of cell death. Cell Death Dis. 2023;14:648.","journal-title":"Cell Death Dis"},{"key":"7926_CR43","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108863","volume":"40","author":"DJ Klionsky","year":"2021","unstructured":"Klionsky DJ, Petroni G, Amaravadi RK, Baehrecke EH, Ballabio A, Boya P, et al. Autophagy in major human diseases. EMBO J. 2021;40:e108863.","journal-title":"EMBO J"},{"key":"7926_CR44","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10495-016-1214-9","volume":"21","author":"LH Zhang","year":"2016","unstructured":"Zhang LH, Yang AJ, Wang M, Liu W, Wang CY, Xie XF, et al. Enhanced autophagy reveals vulnerability of P-gp mediated epirubicin resistance in triple negative breast cancer cells. Apoptosis. 2016;21:473\u201388.","journal-title":"Apoptosis"},{"key":"7926_CR45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.tox.2010.06.010","volume":"276","author":"SC Lim","year":"2010","unstructured":"Lim SC, Hahm KS, Lee SH, Oh SH. Autophagy involvement in cadmium resistance through induction of multidrug resistance-associated protein and counterbalance of endoplasmic reticulum stress WI38 lung epithelial fibroblast cells. Toxicology. 2010;276:18\u201326.","journal-title":"Toxicology"},{"key":"7926_CR46","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2147\/OTT.S185876","volume":"12","author":"T Xu","year":"2019","unstructured":"Xu T, Jiang L, Wang Z. The progression of HMGB1-induced autophagy in cancer biology. Onco Targets Ther. 2019;12:365\u201377.","journal-title":"Onco Targets Ther."},{"key":"7926_CR47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bbamcr.2014.09.023","volume":"1853","author":"C Evangelisti","year":"2015","unstructured":"Evangelisti C, Evangelisti C, Chiarini F, Lonetti A, Buontempo F, Neri LM, et al. Autophagy in acute leukemias: a double-edged sword with important therapeutic implications. Biochim Biophys Acta. 2015;1853:14\u201326.","journal-title":"Biochim Biophys Acta"},{"key":"7926_CR48","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/cbf.3740","volume":"40","author":"H Changotra","year":"2022","unstructured":"Changotra H, Kaur S, Yadav SS, Gupta GL, Parkash J, Duseja A. ATG5: a central autophagy regulator implicated in various human diseases. Cell Biochem Funct. 2022;40:650\u201367.","journal-title":"Cell Biochem Funct"},{"key":"7926_CR49","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41418-022-01107-8","volume":"30","author":"Z Gao","year":"2023","unstructured":"Gao Z, Li C, Sun H, Bian Y, Cui Z, Wang N, et al. N(6)-methyladenosine-modified USP13 induces pro-survival autophagy and imatinib resistance via regulating the stabilization of autophagy-related protein 5 in gastrointestinal stromal tumors. Cell Death Differ. 2023;30:544\u201359.","journal-title":"Cell Death Differ"},{"key":"7926_CR50","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.biocel.2019.01.020","volume":"111","author":"ZC Wang","year":"2019","unstructured":"Wang ZC, Huang FZ, Xu HB, Sun JC, Wang CF. MicroRNA-137 inhibits autophagy and chemosensitizes pancreatic cancer cells by targeting ATG5. Int J Biochem Cell Biol. 2019;111:63\u201371.","journal-title":"Int J Biochem Cell Biol"},{"key":"7926_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100915","volume":"67","author":"Z Yu","year":"2023","unstructured":"Yu Z, Tang H, Chen S, Xie Y, Shi L, Xia S, et al. Exosomal LOC85009 inhibits docetaxel resistance in lung adenocarcinoma through regulating ATG5-induced autophagy. Drug Resist Updat. 2023;67:100915.","journal-title":"Drug Resist Updat"},{"key":"7926_CR52","doi-asserted-by":"publisher","first-page":"5151","DOI":"10.1093\/nar\/gkp546","volume":"37","author":"K Tsuda","year":"2009","unstructured":"Tsuda K, Kuwasako K, Takahashi M, Someya T, Inoue M, Terada T, et al. Structural basis for the sequence-specific RNA-recognition mechanism of human CUG-BP1 RRM3. Nucleic Acids Res. 2009;37:5151\u201366.","journal-title":"Nucleic Acids Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07926-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07926-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07926-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T18:29:39Z","timestamp":1757356179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07926-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7926"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07926-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Medical Ethics Committee of Hangzhou Medical College(No.2021-106). All animal care procedures and experiments were performed according to the guidelines of the Institutional Animal Care and Use Committee (IACUC) guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"599"}}